| Descriptor English: | Gemtuzumab | ||||||
| Descriptor Spanish: |
Gemtuzumab
| ||||||
| Descriptor Portuguese: | Gemtuzumab | ||||||
| Descriptor French: | Gemtuzumab | ||||||
| Entry term(s): |
CMA 676 CMA-676 CMA676 Gemtuzumab Ozogamicin Gemtuzumab-Ozogamicin Mylotarg |
||||||
| Tree number(s): |
D09.408.051.247.500 D12.776.124.486.485.114.224.060.790 D12.776.124.790.651.114.224.060.790 D12.776.377.715.548.114.224.200.790 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000079982 | ||||||
| Scope note: | Immunotoxin that consists of an anti-CD33 (CD33 ANTIGEN) monoclonal antibody conjugated to CALICHEAMICIN. It is used for the treatment of ACUTE MYELOID LEUKEMIA. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification DE drug effects EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Pharm Action: |
Antineoplastic Agents, Immunological Immunotoxins |
||||||
| Registry Number: | 93NS566KF7 | ||||||
| Public MeSH Note: | 2020; GEMTUZUMAB was indexed under AMINOGLYCOSIDES and ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2019; and under ANTIBODIES, MONOCLONAL 2000-2011 |
||||||
| History Note: | 2020 (2000) |
||||||
| DeCS ID: | 59111 | ||||||
| Unique ID: | D000079982 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2020/01/01 | ||||||
| Date of Entry: | 2019/07/08 | ||||||
| Revision Date: | 2019/04/29 |
-
-
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
|
Gemtuzumab
- Preferred
Mylotarg
- Narrower
Gemtuzumab Ozogamicin
- Narrower
CMA 676
- Narrower
| Concept UI |
M0398183 |
| Scope note | Immunotoxin that consists of an anti-CD33 (CD33 ANTIGEN) monoclonal antibody conjugated to CALICHEAMICIN. It is used for the treatment of ACUTE MYELOID LEUKEMIA. |
| Preferred term | Gemtuzumab |
| Concept UI |
M0374887 |
| Preferred term | Mylotarg |
| Concept UI |
M0483090 |
| Preferred term | Gemtuzumab Ozogamicin |
| Entry term(s) |
Gemtuzumab-Ozogamicin |
| Concept UI |
M0360010 |
| Preferred term | CMA 676 |
| Entry term(s) |
CMA-676 CMA676 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
